The impact of age on general and bladder cancer-specific quality of life among bladder cancer survivors.

Authors

Pauline Filippou

Pauline Filippou

University of North Carolina Hospitals, Chapel Hill, NC

Pauline Filippou , Sean McCabe , Hannah McCloskey , Kathryn Gessner , Judy Hamad , Allison Mary Deal , Angela Smith , John L. Gore

Organizations

University of North Carolina Hospitals, Chapel Hill, NC, University of North Carolina at Chapel Hill, Chapel Hill, NC, Lineberger Comprehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill, NC, University of Washington Medical Center, Seattle, WA

Research Funding

Other
Bladder Cancer Advocacy Network Patient Survey Network Grant

Background: Quality of life among cancer survivors has been shown to vary by age. Our objective was to evaluate differences in general and bladder cancer-specific quality of life based on age among a large cross-sectional bladder cancer cohort. Methods: We performed a cross-sectional survey of bladder cancer patients using the Bladder Cancer Advocacy Network Patient Survey Network and Inspire platforms to determine general and bladder cancer-specific quality of life (QOL) using the EORTC QLQ-C30 and Bladder Cancer Index. Patients were also queried regarding demographic, socioeconomic and clinical characteristics. We present descriptive statistics and a multiple linear regression model to identify factors independently associated with QOL domain score. Results: 972 respondents self-identified as patients with bladder cancer, of whom 41% were female and 97 % were white. The mean age was 67.6 years (range 29 to 93 years). Respondents were highly educated (67% completed college). 63% of patients identified as having non-invasive (NMIBC) cancer (n=578), 30% had MIBC (n=270), and 7% had metastatic bladder cancer (n=63). On multivariable analysis, older age was significantly associated with better generic QOL and urinary function (Table), but not sexual function (p=0.19) or bowel function (p=0.73), controlling for sex, race, stage, comorbidity and years since diagnosis. Conclusions: Higher general and domain-specific QOL scores are more common among older bladder cancer patients. Differential impact by age may be important for the development of tailored interventions to improve QOL for bladder cancer patients.

<55 years
55-64 years
>=65 years
p-value
N=Mean (SD)N=Mean (SD)N=Mean (SD)
EORTC QLQ-C3013582.57 (13.5)17383.96 (12.8)52885.89 (11.4)0.0085
BCI-Urinary10481.92 (19.4)18383.25 (16.3)56286.59 (15.1)0.0035
BCI-Sexual9351.77 (27.8)17646.76 (24.9)50446.68 (24.8)0.1918
BCI-GI10358.44 (12.1)56960.02 (11.2)56960.02 (11.2)0.3944

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 463)

Abstract #

463

Poster Bd #

G8

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

Yoga vs. behavioral placebo for fatigue and quality of life among older cancer survivors.

First Author: Evelyn Arana

Abstract

2023 ASCO Annual Meeting

Sleep health and quality of life in African American cancer survivors: The Detroit ROCS Cohort.

First Author: Jennifer Lynn Beebe-Dimmer